PTC
IRWD icon

Private Trust Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Trust Company’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-26
Closed -$277 – 2353
2023
Q2 		$277 Hold
26
– – ﹤0.01% 2250
2023
Q1 		$274 Hold
26
– – ﹤0.01% 2219
2022
Q4 		$0 Hold
26
– – ﹤0.01% 2216
2022
Q3 		$0 Hold
26
– – ﹤0.01% 2106
2022
Q2 		$0 Buy
+26
New +$306 ﹤0.01% 2114
2014
Q4 		– Sell
-62
Closed -$1K – 728
2014
Q3 		$1K Hold
62
– – ﹤0.01% 1749
2014
Q2 		$1K Buy
62
+43
+226% +$468 ﹤0.01% 1775
2014
Q1 		$0 Buy
+19
New +$214 ﹤0.01% 1849

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Private Trust Company's IRWD Position: Q3 2023 in Review

Private Trust Company sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 26 shares — an estimated $277 sold.

Private Trust Company first reported a position in IRWD in Q1 2014 and held it in 8 quarters. The position peaked at $1K in Q3 2014. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

  • Private Trust Company reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Private Trust Company sold 26 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $277.
  • Private Trust Company first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 8 quarters.
  • Private Trust Company's Ironwood Pharmaceuticals position peaked at $1K in Q3 2014.
  • 248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Private Trust Company's 13F filing for Q3 2023, filed 18 Oct 2023.